A Russian state virology institute has started clinical trials of the country's second potential COVID-19 vaccine, injecting the first of five volunteers with a dose on July 27, as reported This is Money on Tuesday.
The next participant in the trial by the Vector virology institute in Siberia will receive a dose on July 30.
The trial is expected to include 100 volunteers between the ages of 18 and 60.
World Health Organization records show that Vector is working on six different potential COVID-19 vaccines.
Meanwhile, the Gamaleya Institute completed early clinical trials of an adenovirus-based vaccine earlier this month and expects to enter large-scale trials in August.
To read more NewsPoints articles, click here.